{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:14:48Z","timestamp":1764785688747,"version":"3.30.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.74957","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:17:49Z","timestamp":1733138269000},"source":"Crossref","is-referenced-by-count":0,"title":["The Appropriate Utilization of Beta-Blockers in Acute Coronary Syndrome Patients: An Improvement Initiative"],"prefix":"10.7759","author":[{"given":"Binayendu","family":"Prakash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reeta R","family":"Mohanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar M","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000134","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam EA","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al.. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014, 130:e344-426. 10.1161\/CIR.0000000000000134","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara PT","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013, 127:e362-425. 10.1161\/CIR.0b013e3182742cf6","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi M","year":"2016","unstructured":"Roffi M, Patrono C,Collet JP, et al.. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016, 37:267-315. 10.1093\/eurheartj\/ehv320","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle N","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999, 318:1730-7. 10.1136\/bmj.318.7200.1730","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01913-7","article-title":"Current role of beta blockers in cardiovascular therapy","volume":"40","author":"Packer M","year":"2002","unstructured":"Packer M. Current role of beta blockers in cardiovascular therapy. J Am Coll Cardiol. 2002, 40:185-90. 10.1016\/S0735-1097(02)01913-7","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori SG","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al.. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015, 36:2793-867. 10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.05.016","article-title":"Efficacy of beta blockade in ischemic heart disease","volume":"118","author":"Kloner RA","year":"2016","unstructured":"Kloner RA. Efficacy of beta blockade in ischemic heart disease. Am J Cardiol. 2016, 118:227-33. 10.1016\/j.amjcard.2016.05.016","journal-title":"Am J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00501-8","article-title":"Beta blocker use in acute myocardial infarction","volume":"78","author":"Viskin S","year":"1996","unstructured":"Viskin S, Barron HV. Beta blocker use in acute myocardial infarction. Am J Cardiol. 1996, 78:821-2. 10.1016\/S0002-9149(96)00501-8","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e318188bdca","article-title":"beta-Adrenergic blockers: a 50-year historical perspective","volume":"15","author":"Frishman WH","year":"2008","unstructured":"Frishman WH. beta-Adrenergic blockers: a 50-year historical perspective. Am J Ther. 2008, 15:565-76. 10.1097\/MJT.0b013e318188bdca","journal-title":"Am J Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.047","article-title":"Effect of beta-blocker dose on survival after acute myocardial infarction","volume":"66","author":"Goldberger JJ","year":"2015","unstructured":"Goldberger JJ, Bonow RO, Cuffe M, et al.. Effect of beta-blocker dose on survival after acute myocardial infarction. J Am Coll Cardiol. 2015, 66:1431-41. 10.1016\/j.jacc.2015.07.047","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142030-00007","article-title":"Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders","volume":"42","author":"Wadworth AN","year":"1991","unstructured":"Wadworth AN, Murdoch D, Brogden RN. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs. 1991, 42:468-510. 10.2165\/00003495-199142030-00007","journal-title":"Drugs"},{"key":"ref12","article-title":"Beta-blockers in reperfusion therapy","volume":"14","author":"L\u00e9vy S","year":"1993","unstructured":"L\u00e9vy S. Beta-blockers in reperfusion therapy. Eur Heart J. 1993, 14:198-203.","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.14.1766","article-title":"Utilization of beta-blockers post-MI: global perspectives","volume":"287","author":"Yusuf S","year":"2002","unstructured":"Yusuf S. Utilization of beta-blockers post-MI: global perspectives. JAMA. 2002, 287:1766-74. 10.1001\/jama.287.14.1766","journal-title":"JAMA"},{"key":"ref14","article-title":"Barriers to guideline implementation in ACS","volume":"68","author":"Bhatt DL","year":"2016","unstructured":"Bhatt DL. Barriers to guideline implementation in ACS. J Am Coll Cardiol. 2016, 68:102-11.","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S65753","article-title":"Beta-blockers in acute myocardial infarction: review of indications and use","volume":"10","author":"Roxburgh J","year":"2014","unstructured":"Roxburgh J. Beta-blockers in acute myocardial infarction: review of indications and use. Ther Clin Risk Manag. 2014, 10:221-35. 10.2147\/TCRM.S65753","journal-title":"Ther Clin Risk Manag"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102350-the-appropriate-utilization-of-beta-blockers-in-acute-coronary-syndrome-patients-an-improvement-initiative","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:17:51Z","timestamp":1733138271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102350-the-appropriate-utilization-of-beta-blockers-in-acute-coronary-syndrome-patients-an-improvement-initiative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.74957","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}